30 related articles for article (PubMed ID: 9414418)
1. Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids.
Jiménez-López JM; Ríos-Marco P; Marco C; Segovia JL; Carrasco MP
Lipids Health Dis; 2010 Mar; 9():33. PubMed ID: 20338039
[TBL] [Abstract][Full Text] [Related]
2. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes.
Rakotomanga M; Blanc S; Gaudin K; Chaminade P; Loiseau PM
Antimicrob Agents Chemother; 2007 Apr; 51(4):1425-30. PubMed ID: 17242145
[TBL] [Abstract][Full Text] [Related]
3. The interference effects of hexadecylphosphocholine on proliferation and membrane phospholipid metabolism in human myeloid leukemia cell lines.
Wang YZ; Chang YB; Xing C; Fu D
Int J Tissue React; 1998; 20(3):101-7. PubMed ID: 9894183
[TBL] [Abstract][Full Text] [Related]
4. Hexadecylphosphocholine does not influence phospholipase D and sphingomyelinase activity in human leukemia cells.
Berkovic D; Berkovic K; Binder C; Haase D; Fleer EA
J Exp Ther Oncol; 2002; 2(4):213-8. PubMed ID: 12416025
[TBL] [Abstract][Full Text] [Related]
5. Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues.
Berkovic D; Haase D; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Nov; 1(6):368-75. PubMed ID: 9414427
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells.
Plo I; Lautier D; Levade T; Sekouri H; Jaffrézou JP; Laurent G; Bettaïeb A
Biochem J; 2000 Oct; 351 Pt 2(Pt 2):459-67. PubMed ID: 11023832
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of phospholipase A2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine.
Berkovic D; Lüders S; Goeckenjan M; Hiddemann W; Fleer EA
Biochem Pharmacol; 1997 Jun; 53(11):1725-33. PubMed ID: 9264326
[TBL] [Abstract][Full Text] [Related]
8. Hexadecylphosphocholine inhibits phosphatidylinositol and phosphatidylcholine phospholipase C in human leukemia cells.
Berkovic D; Goeckenjan M; Lüders S; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Sep; 1(5):302-11. PubMed ID: 9414418
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanisms for feedback regulation of phospholipase C-beta activity.
Litosch I
IUBMB Life; 2002 Nov; 54(5):253-60. PubMed ID: 12587975
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phosphatidylcholine synthesis is not the primary pathway in hexadecylphosphocholine-induced apoptosis.
van der Sanden MH; Houweling M; Duijsings D; Vaandrager AB; van Golde LM
Biochim Biophys Acta; 2004 Mar; 1636(2-3):99-107. PubMed ID: 15164757
[TBL] [Abstract][Full Text] [Related]
11. Cellular transport and lipid interactions of miltefosine.
Barratt G; Saint-Pierre-Chazalet M; Loiseau PM
Curr Drug Metab; 2009 Mar; 10(3):247-55. PubMed ID: 19442087
[TBL] [Abstract][Full Text] [Related]
12. Alkylphosphocholines: a new class of membrane-active anticancer agents.
Hilgard P; Klenner T; Stekar J; Unger C
Cancer Chemother Pharmacol; 1993; 32(2):90-5. PubMed ID: 8485813
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
